Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03915184
Title Clinical Trial to Evaluate CT053 in Patients With Relapsed and/or Refractory Multiple Myeloma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Carsgen Therapeutics, Ltd.

multiple myeloma


Anti-BCMA CAR T Cells

Age Groups: adult | senior
Covered Countries USA | CAN

No variant requirements are available.